Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
94,179,674
-
Total 13F shares
-
32,726,927
-
Share change
-
+2,186,784
-
Total reported value
-
$616,934,642
-
Price per share
-
$18.85
-
Number of holders
-
81
-
Value change
-
+$43,330,866
-
Number of buys
-
59
-
Number of sells
-
19
Institutional Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q2 2021
As of 30 Jun 2021 Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) had 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 32,726,927 shares of stock of the company.
Largest 10 holders included FMR LLC, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, BlackRock Inc., Vivo Capital, LLC, Bain Capital Life Sciences Investors, LLC, VANGUARD GROUP INC, 5AM Venture Management, LLC, and BAKER BROS. ADVISORS LP.
This table shows 81 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.